MORPHINE AND NOREPINEPHRINE-INDUCED ANTINOCICEPTION AT THE SPINAL LEVEL IS MEDIATED BY ADENOSINE

被引:28
|
作者
YANG, SW
ZHANG, ZH
CHEN, JY
XIE, YF
QIAO, JT
DAFNY, N
机构
[1] UNIV TEXAS, SCH MED, DEPT NEUROBIOL & ANAT, HOUSTON, TX 77025 USA
[2] SHANXI MED COLL, DEPT NEUROBIOL, TAIYUAN 030001, PEOPLES R CHINA
关键词
ADENOSINE; MORPHINE; SEROTONIN; NOREPINEPHRINE; AMINOPHYLLINE; ANTINOCICEPTION; SPINAL CORD;
D O I
10.1097/00001756-199407000-00009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE purpose of this study was to examine whether adenosine or serotonin is involved in mediation of the antinociception produced by norepinephrine at the spinal cord level. Aminophylline, an adenosine receptor antagonist and naloxone given intrathecally (i.t.) were used to test the antinociception produced by i.t. norepinephrine, serotonin, morphine or the adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine (NECA) by using the tail-flick assay in rats. It was observed that (1) aminophylline blocked the antinociception produced by norepinephrine, but exhibited no effect on the antinociception produced by serotonin, (2) aminophylline blocked the antinociception produced by morphine similarly to naloxone, (3) aminophylline blocked the antinociception produced by NECA and (4) naloxone failed to block the antinociception produced by NECA and serotonin. The results suggest that adenosine is involved in mediation of the norepinephrine-produced antinociception at the spinal level and that norepinephrine and adenosine may act in a sequential manner in norepinephrine-induced antinociception.
引用
收藏
页码:1441 / 1444
页数:4
相关论文
共 50 条
  • [31] Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine
    Buhler, A. V.
    Proudfit, H. K.
    Gebhart, G. F.
    [J]. PAIN, 2008, 135 (03) : 280 - 290
  • [32] ADENOSINE KINASE AND ADENOSINE-DEAMINASE INHIBITION MODULATE SPINAL ADENOSINE-INDUCED AND OPIOID AGONIST-INDUCED ANTINOCICEPTION IN MICE
    KEIL, GJ
    DELANDER, GE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (01) : 37 - 46
  • [33] NOREPINEPHRINE-INDUCED NA+ INFLUX IN BROWN ADIPOCYTES IS CYCLIC AMP-MEDIATED
    CONNOLLY, E
    NANBERG, E
    NEDERGAARD, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (31) : 4377 - 4385
  • [34] Interactions of galanin and morphine in the spinal antinociception in rats with mononeuropathy
    Zhang, YP
    Lundeberg, T
    Yu, LC
    [J]. BRAIN RESEARCH, 2000, 852 (02) : 485 - 487
  • [35] Involvement of spinal cholecystokinin in the attenuation of morphine-induced antinociception following electroacupuncture in rat
    Fukazawa, Yohji
    Maeda, Takehiko
    Hamabe, Wakako
    Yamamoto, Chizuko
    Tohya, Kazuo
    Kuribayashi, Koichi
    Kimura, Michio
    Kishioka, Shiroh
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 107 - 107
  • [36] NOREPINEPHRINE-INDUCED FATTY LIVER AND HYPOCALCEMIA IN SHEEP
    LUTHMAN, J
    HOLTENIUS, P
    [J]. ACTA VETERINARIA SCANDINAVICA, 1972, 13 (01) : 31 - +
  • [37] Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model
    Kroin, JS
    Buvanendran, A
    McCarthy, RJ
    Hemmati, H
    Tuman, KJ
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2002, 27 (05) : 451 - 455
  • [38] Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of α2-adrenoceptors
    Yang, SL
    Zhou, M
    Chaudry, IH
    Wang, P
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (04): : G1014 - G1021
  • [39] ATP-sensitive K+ channels are involved in the mediation of intrathecal norepinephrine- or morphine-induced antinociception at the spinal level:: A study using EMG planimetry of flexor reflex in rats
    Kang, YM
    Zhang, ZH
    Yang, SW
    Qiao, JT
    Dafny, N
    [J]. BRAIN RESEARCH BULLETIN, 1998, 45 (03) : 269 - 273
  • [40] Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats
    Laycock, SK
    Kane, KA
    McMurray, J
    Parratt, JR
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (05) : 667 - 672